Mr. Rajdeep Panwar

Thyrocare invites analysts to a conference call on May 12, 2026, to discuss its audited Q4 and FY26 results. The call, arranged per SEBI Listing Regulation 30, will feature the Chairman, MD, CEO, CFO,